M&A Deal Summary

Exponent Private Equity Acquires BBI Group

On July 16, 2015, private equity firm Exponent Private Equity acquired life science company BBI Group from Alere for 164M USD

Acquisition Highlights
  • This is Exponent Private Equity’s 1st transaction in the Life Science sector.
  • This is Exponent Private Equity’s 14th largest (disclosed) transaction.
  • This is Exponent Private Equity’s 17th transaction in the United Kingdom.
Investment Fate
  • BBI Group was sold to a consortium of financial buyers in 2021 for 400M GBP.

M&A Deal Summary
Date 2015-07-16
Target BBI Group
Sector Life Science
Buyer(s) Exponent Private Equity
Sellers(s) Alere
Deal Type Divestiture
Deal Value 164M USD

Target

BBI Group

Crumlin, United Kingdom
BBI Group is a provider of immunoassay development and manufacturing services, and provides an extensive portfolio of products and technologies to the global diagnostic market. It provides products and services for the diagnostic, healthcare, research, defense, and food industries globally. BBI Group was formed in 1986 and is based in Crumlin, United Kingdom.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Exponent Private Equity

London, United Kingdom

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2004
PE ASSETS 2.9B GBP
Size Large
Type Sector Agnostic
DESCRIPTION

Exponent is a private equity firm focused on acquiring middle-market businesses located in the UK and broader Europe. Exponent targets opportunities in the media, business and financial services, healthcare, consumer, and leisure sectors. The Firm seeks to invest in businesses valued from £150 to £500 million. Exponent has a particular interest in businesses that are prominent in their respective markets, but may benefit from or need operational improvement. Exponent Private Equity was formed in 2004 and is based in London.

DEAL STATS #
Overall 19 of 38
Sector (Life Science) 1 of 1
Type (Divestiture) 4 of 12
Country (United Kingdom) 17 of 32
Year (2015) 2 of 4
Size (of disclosed) 14 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-02-24 Big Bus Tours

London, United Kingdom

Big Bus Tours is a provider of sightseeing bus tours globally. They operate in 16 of the world’s busiest and most beautiful tourist destinations, including London, Paris, New York, Washington, San Francisco, Dubai, Hong Kong and Istanbul. Big Bus Tours is based in London.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-30 Quorn Foods

Westport, Connecticut, United States

Quorn Foods trades under the brands Quorn and Cauldron. Quorn is a UK market leader in meat-alternative foods and is one of the largest meat-alternative brands in the world.

Sell £550M

Seller(S) 1

SELLER

Alere

Waltham, Massachusetts, United States
Category Company
Founded 1981
Sector Healthcare Services
Employees9,800
Revenue 2.6B USD (2014)
DESCRIPTION

Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Alere was founded in 1981 and is based in Waltham, Massachusetts.

DEAL STATS #
Overall 3 of 5
Sector (Life Science) 1 of 1
Type (Divestiture) 3 of 5
Country (United Kingdom) 1 of 1
Year (2015) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-07-16 US Diagnostics

West Palm Beach, Florida, United States

US Diagnostics, Inc. is a provider of drug testing devices,

Buy $60M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-07-17 Alere - Triage Assets

Waltham, Massachusetts, United States

Alere, Inc. - Triage Assets includes MeterPro cardiovascular (CV) and toxicology assets (“Triage business”) and the B-type Naturietic Peptide (BNP) assay business run on Beckman Coulter analyzers (“BNP business”).

Sell -
Mergr

Product

Company

Legal